{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:34:43Z","timestamp":1793666083135,"version":"4.5.1"},"reference-count":16,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Grant for Implementation of Advanced Medicine","award":["119"],"award-info":[{"award-number":["119"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,10,30]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic subdural haematoma (CSDH) is a common neurosurgical condition in older adults, with a recurrence rate of approximately 7.1\u201313% after burr-hole drainage. Although surgical adjuncts such as subdural drains and middle meningeal artery embolisation may reduce recurrence, these are not suitable for all patients. Pharmacological strategies, including tranexamic acid, Goreisan and carbazochrome sodium sulfonate hydrate, have shown potential, but high-level evidence remains lacking. A prior retrospective study suggested that a triple oral regimen combining these agents may reduce recurrence. This randomised controlled trial aims to evaluate its efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, multicentre, open-label, randomised controlled trial conducted across six hospitals in Ibaraki, Japan. A total of 180 patients undergoing first-time burr-hole surgery for CSDH will be randomised 1:1 to receive either triple therapy (Goreisan 7.5\u2009g\/day, carbazochrome sodium sulfonate hydrate 90\u2009mg\/day and tranexamic acid 750\u2009mg\/day for up to 90 days) or standard postoperative care. The primary outcome is recurrence requiring reoperation within 90 days. Secondary outcomes include time to recurrence and haematoma volume reduction on serial CT imaging. All analyses will follow the intention-to-treat principle, using logistic regression, Cox proportional hazards models and mixed-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      Written, informed consent will be obtained from all participants at each participating hospital by trained staff from that hospital. The trial protocol has been approved by the ethics committee of the University of Tsukuba Hospital (approval no. TCRB23-025) and the Institutional Review Boards of all participating centres. Study findings will be disseminated through presentations at scientific conferences and publications in peer-reviewed journals. A summary of the results will also be provided to participating institutions and made publicly available in accordance with the\n                      <jats:italic>BMJ Open<\/jats:italic>\n                      data sharing policy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>jRCTs031240007.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-110016","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T18:35:40Z","timestamp":1765564540000},"page":"e110016","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Triple-drug therapy with Goreisan, tranexamic acid and carbazochrome sodium sulfonate hydrate to prevent recurrence after chronic subdural haematoma surgery: a multicentre, randomised, controlled trial protocol"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0458-9306","authenticated-orcid":false,"given":"Haruka","family":"Negishi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Mito Medical Center, Higashiibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-500X","authenticated-orcid":false,"given":"Koji","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Aiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tsukuba Memorial Hospital, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ibaraki Seinan Medical Center Hospital, Sashima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hitachi General Hospital, Hitachi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mito Medical Center, Higashiibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mito Kyodo General Hospital, Mito, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ibaraki Seinan Medical Center Hospital, Sashima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomosato","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hitachi General Hospital, Hitachi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mito Medical Center, Higashiibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-8665","authenticated-orcid":false,"given":"Shinya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mito Kyodo General Hospital, Mito, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narushi","family":"Sugii","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tsukuba Medical Center Hospital, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J","family":"Mathis","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9630-5882","authenticated-orcid":false,"given":"Tomohiro","family":"Ohigashi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Tsukuba Clinical Research & Development Organization (T-CReDO), University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Endo","sequence":"additional","affiliation":[{"name":"Tsukuba Clinical Research and Development Organization (T-CReDO), University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumaru","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2026010703464241000_15.12.e110016.1","doi-asserted-by":"publisher","DOI":"10.3171\/2014.9.JNS141550"},{"key":"2026010703464241000_15.12.e110016.2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3171\/2018.12.JNS183035","article-title":"The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population","volume":"132","author":"Rauhala","year":"2020","journal-title":"J Neurosurg"},{"key":"2026010703464241000_15.12.e110016.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61115-6"},{"key":"2026010703464241000_15.12.e110016.4","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz095"},{"key":"2026010703464241000_15.12.e110016.5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1227\/ons.0000000000000794","article-title":"Recurrent Chronic Subdural Hematoma After Burr-Hole Surgery and Postoperative Drainage: A Systematic Review and Meta-Analysis","volume":"25","author":"Lodewijkx","year":"2023","journal-title":"Oper Neurosurg"},{"key":"2026010703464241000_15.12.e110016.6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2176\/nmc.41.382","article-title":"Clinical factors of recurrent chronic subdural hematoma","volume":"41","author":"Oishi","year":"2001","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2026010703464241000_15.12.e110016.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313472"},{"key":"2026010703464241000_15.12.e110016.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409845"},{"key":"2026010703464241000_15.12.e110016.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401201"},{"key":"2026010703464241000_15.12.e110016.10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.2025.7583","article-title":"Meningeal Embolization for Preventing Chronic Subdural Hematoma Recurrence After Surgery: The EMPROTECT Randomized Clinical Trial","volume":"334","author":"Shotar","year":"2025","journal-title":"JAMA"},{"key":"2026010703464241000_15.12.e110016.11","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1056\/NEJMoa2020473","article-title":"Trial of Dexamethasone for Chronic Subdural Hematoma","volume":"383","author":"Hutchinson","year":"2020","journal-title":"N Engl J Med"},{"key":"2026010703464241000_15.12.e110016.12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamaneurol.2018.2030","article-title":"Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial","volume":"75","author":"Jiang","year":"2018","journal-title":"JAMA Neurol"},{"key":"2026010703464241000_15.12.e110016.13","doi-asserted-by":"crossref","first-page":"108434","DOI":"10.1016\/j.clineuro.2024.108434","article-title":"The efficacy and safety of the internal medication therapy of the triple drugs for chronic subdural hematoma: Retrospective analysis","volume":"244","author":"Hirata","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"2026010703464241000_15.12.e110016.14","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/j.wneu.2019.10.134","article-title":"Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery","volume":"134","author":"Yamada","year":"2020","journal-title":"World Neurosurg"},{"key":"2026010703464241000_15.12.e110016.15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2176\/nmc.oa.2020-0287","article-title":"A Prospective Randomized Study on the Preventive Effect of Japanese Herbal Kampo Medicine Goreisan for Recurrence of Chronic Subdural Hematoma","volume":"61","author":"Fujisawa","year":"2021","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2026010703464241000_15.12.e110016.16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3171\/2024.1.JNS232463","article-title":"Efficacy and safety of tranexamic acid in the management of chronic subdural hematoma: a systematic review and meta-analysis","volume":"141","author":"Musmar","year":"2024","journal-title":"J Neurosurg"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-110016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:47:59Z","timestamp":1767786479000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-110016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-110016"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-110016","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}